ClearPoint Neuro Inc. (CLPT): Kapitalisasi marang pendapatan
The price/sales multiple of ClearPoint Neuro, Inc. (CLPT) reflects the business valuation trend, where the current status is 6.00. Rising demand for brain gene therapy is expanding the precision navigation niche. The integration of software and platforms creates a strong dependency of clinics on the ecosystem. However, the high cost of robots and reductions in government equipment budgets create significant financial risks for ClearPoint Neuro, Inc. (CLPT).
Rincian analitis perusahaan ClearPoint Neuro, Inc. (CLPT)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal ClearPoint Neuro, Inc.|CLPT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas clearpointneuro.com|CLPT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ClearPoint|CLPT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ClearPoint Neuro|Rasio jangkoan perantara clearpointneuro.com
- data bathi lan kelipatan valuasi:
CLPT - Bathi resik|Bathi resik sing dikarepake ClearPoint Neuro, Inc.|CLPT - Rasio rega marang bathi|Pangali forward rega marang bathi clearpointneuro.com|CLPT - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA ClearPoint|CLPT - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan ClearPoint Neuro|CLPT - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan clearpointneuro.com|CLPT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep ClearPoint Neuro, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:CLPT ClearPoint Neuro Inc.
The P/S multiple compares a business's market value to its actual revenue stream, allowing an investor to determine the degree of an asset's overvaluation regardless of current earnings. By analyzing the price-to-sales ratio, one can understand how the market discounts ClearPoint Neuro, Inc. (CLPT) R&D expenditures relative to the growing demand for neurosurgical systems, which confirms the corporation's operational resilience.
Pesaing ClearPoint Neuro, Inc.
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan Stereotaxis Corp|Kapitalisasi marang pendapatan Neuronetics, Inc (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|XTNT: Multiplikator P/S|Kapitalisasi marang pendapatan n1mtc.com|Rasio rega marang pendapatan Modular Medical Inc|Rasio rega marang pendapatan MYO|Multiplikator P/S COCH|VVOS - Rega marang dodolan|Multiplikator P/S NVNO (enVVeno Medical)|Multiplikator P/S Sintx Technologies Inc SINT|TNON - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan LFWD (ReWalk Robotics)|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rasio rega marang dodolan IVF (INVO Fertility Corp)|Rasio rega marang pendapatan Bone Biologics|Rega marang dodolan axonics.com AXNX|Multiplikator P/S BIOL|Koefisien rega marang pendapatan dynatronics.com|Rasio rega marang pendapatan Paragon 28 FNA|INVO: Rasio kapitalisasi marang pendapatan
